Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Year-over-year net income growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-11.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -208.50% |
| Q3 2025 | 11.07% |
| Q2 2025 | -58.78% |
| Q1 2025 | 23.78% |
| Q4 2024 | 4.03% |
| Q3 2024 | -234.80% |
| Q2 2024 | 163.68% |
| Q1 2024 | 10.70% |
| Q4 2023 | -21.25% |
| Q3 2023 | -5.75% |
| Q2 2023 | 4.38% |
| Q1 2023 | 11.37% |
| Q4 2022 | -6.01% |
| Q3 2022 | 25.96% |
| Q2 2022 | -18.51% |
| Q1 2022 | -206.92% |
| Q4 2021 | 174.73% |
| Q3 2021 | 3.30% |
| Q2 2021 | 6.67% |
| Q1 2021 | -32.23% |
| Q4 2020 | 18.83% |
| Q3 2020 | -15.23% |
| Q2 2020 | 12.29% |
| Q1 2020 | -8.81% |
| Q4 2019 | -17.60% |
| Q3 2019 | 4.72% |
| Q2 2019 | 34.38% |
| Q1 2019 | -13.66% |
| Q4 2018 | -21.06% |
| Q3 2018 | -42.87% |
| Q2 2018 | 12.49% |
| Q1 2018 | 1.49% |
| Q4 2017 | -27.42% |
| Q3 2017 | -4.26% |
| Q2 2017 | 1.77% |
| Q1 2017 | -11.07% |
| Q4 2016 | -5.94% |
| Q3 2016 | 15.69% |
| Q2 2016 | -11.45% |
| Q1 2016 | 6.84% |